Evaluation of quality of life among type 2 diabetes patients


  • Shooka Mohammadi Nutrition Sciences Programme, School of Healthcare Sciences, Faculty of Health Sciences, Universiti Kebangsaan Malaysia, Kuala Lumpur
  • Norimah A. Karim Nutrition Sciences Programme, School of Healthcare Sciences, Faculty of Health Sciences, Universiti Kebangsaan Malaysia, Kuala Lumpur
  • Ruzita Abd. Talib Nutrition Sciences Programme, School of Healthcare Sciences, Faculty of Health Sciences, Universiti Kebangsaan Malaysia, Kuala Lumpur
  • Reza Amani Department of Nutrition and Dietetics, Faculty of Para Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz




Type 2 diabetes, Quality of life, Iran


Background: Quality of life (QOL) is an essential part of health outcomes for diabetes patients.

Methods:This cross-sectional study aimed to evaluate the quality of life among 100 Iranian type 2 diabetes patients aged 37 to 66 years, attending the outpatient diabetes clinic at Golestan Hospital, Ahvaz, Iran, from August to October 2013. Diabetes quality of life (DQoL) questionnaire was used to determine quality of life of diabetes patients. Body weight, height, waist circumference, clinical parameters, including glycated hemoglobin A1c level (HbA1c) were also measured.

Results: The mean age of men and women was 56±6.1 and 53.4± 6.7 years respectively. Sixty one present of patients were female and 39 % were male with 4.05 ± 1.4 mean years duration of diabetes. The mean total DQOL was 54.6± 2.4, a moderate quality of life and was associated with diabetes care and treatment adherence. The mean for diabetes-related worry was 77.5 ±7.05.

Conclusions:Male diabetic patients in comparison with female diabetic patients, non-insulin-treated patients compared with insulin-treated patients had better quality of life.  HbA1c higher than 7%, was associated with higher probabilities of worse quality of life among patients. More studies are needed to include larger study populations among Iranian type 2 diabetes patients in order to help health care providers develop proper health care programs for diabetic patients in Iran.


American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2011;34:11-61.

Abolfotouh MA, Salam M, Alturaif D, Suliman W, Al-Essa NA, Al-Issa H. Predictors of QOL and glycemic control among saudi adults with diabetes. International Journal of Medicine and Medical Sciences. 2013;46(4):1360-70.

Al-Lawati JA, Al-Riyami AM, Mohammed AJ, Jousilahti P. Increasing prevalence of diabetes mellitus in Oman. Diabet Med. 2002;19(11):954-7.

Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047–53.

Cherrington AD. Presidential Address: Diabetes: past, present, and future. Diabetes Care. 2006;29(9):2158-64.

International Diabetes Federation. IDF Diabetes Atlas, 5th edn. Brussels, Belgium: International Diabetes Federation, 2011. http://www.idf.org/diabetesatlas.

Saadi H, Carruthers SG, Nagelkerke N, Al-Maskari F, Afandi B, Reed R. Prevalence of diabetes mellitus and its complications in a population-based sample in Al Ain, United Arab Emirates. Diabetes Res Clin Pract.2007;78(3):369-77.

Mabry RM, Reeves MM, Eakin EG, Owen N. Gender differences in prevalence of the metabolic syndrome in Gulf Cooperation Council Countries: a systematic review. Diabet Med. 2010;27(5):593-7.

Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414(6865):782-7.

Yang H, Kaplan S, Reshatoff M, Hu E, Zukowski A, Schweis F. Roka Listeria detection method using transcription mediated amplification to detect Listeria species in select foods and surfaces. Journal of AOAC International. 2012;95(6):1672-88.

Delavari A, Mahdavi-Hezaveh A, Noroozinajad A, Yarahmadi SH. A national design for the prevention and control of diabetes. Tehran: Disease Management Center, Ministry of Health and Medical Education, Iran. 2004.

Esteghamati A, Gouya MM, Abbasi M, Delavari A, Alikhani S, Alaedini F. Prevalence of diabetes and impaired fasting glucose in the adult population of Iran national survey of risk factors for non-communicable diseases of Iran. Diabetes Care. 2008;31(1):96-8.

Fayers PM, Machin D. QOL: the assessment. Analysis and interpretation of patient-related outcomes, 2nd ed. West Sussex: John Wiley & Sons; 2007.

Polonsky WH. Understanding and Assessing Diabetes-Specific QOL. Diabetes Spectrum. 2000;13(1):36-41.

Wandell PE. QOL of patients with diabetes mellitus. An overview of research in primary health care in the Nordic countries. Scand J Prim Health Care. 2005;23(2):68-74.

Chyun DA, Melkus GD, Katten DM, Price WJ, Davey JA, Grey N. The association of psychological factors, physical activity, neuropathy, and QOL in type 2 diabetes. Biological Research for Nursing. 2006;7(4):279-88.

Tang WL, Wang YM, Du WM, Cheng NN, Chen BY. Assessment of QOL and relevant factors in elderly diabetic patients in the Shanghai community. Pharmacoepidemiol Drug Saf. 2006;15(2):123-30.

Clark M. Diabetes self-management education: a review of published studies. Prim Care Diabetes. 2008;2(3):113-20.

Orsenigo E, Fiorina P, Cristallo M, Socci C, La Rocca E, Maffi P. Long-term survival after kidney and kidney-pancreas transplantation in diabetic patients. Transplant Proc. 2004;36(4):1072-5.

Anderson RT, Skovlund SE, Marrero D, Levine DW, Meadows K, Brod M. Development and validation of the insulin treatment satisfaction questionnaire. Clinical therapeutics. 2004;26(4):565-78.

Delavari A, Alikhani S, Nili S, Birjandi RH, Birjandi F. Quality of care of diabetes mellitus type II patients in Iran. Arch Iran Med. 2009;12(5):492-5.

Sayadi N, Fayazi S, Ramezani A. Assessing QOL after open heart surgery in diabetic and non-diabetic patients. Journal of Rafsanjan University of Medical Sciences. 2011;10:144–150.

Javanbakht M, Abolhasani F, Mashayekhi A, Baradaran HR. Health related QOL in patients with type 2 diabetes mellitus in Iran: a national survey. PloS one. 2012;7:44526.

Davis TM, Clifford RM, Davis, WA. Fremantle Diabetes Study: Effect of insulin therapy on QOL in Type 2 diabetes mellitus: The Fremantle Diabetes Study. Diabetes Res Clin Pract. 2001;52(1):63-71.

Chesla CA , Fisher L , Mullan JT, Skaff MM, Gardiner P, Chun K. Family and disease management in African-American patients with type 2 diabetes. Diabetes Care. 2004;27(12):2850-5.

Pakpour AH, Saffari M , Burri A. Translation and validation of an Iranian version of the Diabetes QOL measure. Journal of diabetes investigation. 2012;3(5):471-8.

Azimi-Nezhad M, Ghayour-Mobarhan M, Parizadeh MR, Safarian M, Esmaeili H, Parizadeh S. Prevalence of type 2 diabetes mellitus in Iran and its relationship with gender, urbanization, education, marital status and occupation. Singapore Med J. 2008;49(7):571-57.

Abdel-Gawad E. QOL in Saudis with diabetes. Saudi J Disabil. 2002;8:163-8.

World Health Organization. Reducing risks and promoting healthy life. Geneva: WHO; 2008.

Unden AL, Elofsson S, Andreasson A, Hillered E, Eriksson I, Brismar K. Gender differences in self-rated health, QOL, quality of care, and metabolic control in patients with diabetes. Gend Med. 2008;5(2):162-80.

Mikailiukstiene A, Juozulynas A, Narkauskaite L, Zagminas K, Salyga J, Stukas R. QOL in relation to social and disease factors in patients with type 2 diabetes in Lithuania. Med Sci Monit. 2013;19:165-74.

Grant JF, Hicks N, Taylor AW, Chittleborough CR, Phillips PJ. North West Adelaide Health Study Team. Gender-specific epidemiology of diabetes: a representative cross-sectional study. Int J Equity Health. 2009;8(1):6.

Eljedi A, Mikolajczyk RT, Kraemer A, Laaser U. Health-related QOL in diabetic patients and controls without diabetes in refugee camps in the Gaza strip: a cross-sectional study. BMC Public Health. 2006;6(1):268.

Kiadaliri AA, Najafi B, Mirmalek-Sani M. QOL in people with diabetes: a systematic review of studies in Iran. J. Diabetes Metab. Disord. 2013;12:1-10.

Redekop WK, Koopmanschap MA, Stolk RP, Rutten GE, Wolffenbuttel BH, Niessen LW. Health-related QOL and treatment satisfaction in Dutch patients with type 2 diabetes. Diabetes Care. 2002;25(3):458-63.

Yildirim A. Health-related quality of social life. Gulhane Medical Journal. 2002;44:480-5.

Akinci F, Yildirim A, Gozu H, Sargin H, Orbay E, Sargin M. Assessment of health-related QOL (HRQoL) of patients with type 2 diabetes in Turkey. Diabetes Res Clin Pract. 2008;79(1):117-23.

Al-Maskari MY, Al-Shookri AO, Al-Adawi SH, Lin KG. Assessment of QOL in patients with type 2 diabetes mellitus in Oman. Saudi medical journal. 2011;32(12):1285-90.

Saito I, Inami F, Ikebe T, Moriwaki C, Tsubakimoto A, Yonemasu K. Impact of diabetes on health-related QOL in a population study in Japan. Diabetes Res Clin Pract. 2006;19:163-73.

Wexler DJ, Grant RW, Wittenberg E, Wittenberg E, Bosch JL, Cagliero E, et al. Correlates of health-related QOL in type 2 diabetes. Diabetologia. 2006;49(7):1489-97.

Brown DW, Balluz LS, Giles WH, Beckles GL, Moriarty DG, Ford ES. Diabetes mellitus and health-related QOL among older adults: Findings from the behavioral risk factor surveillance system (BRFSS). Diabetes Research and Clinical Practice. 2004;65(2):105-15.

Shrestha P, Ghimire LA. Review about the Effect of Life style Modification on Diabetes and QOL. Global Journal of Health Science. 2012; 4(6):185-190.

Mittal A, Sathian B, Kumar A, Chandrasekharan N, Sunka A. Diabetes mellitus as a Potential Risk Factor for Renal Disease among Nepalese: A Hospital Based Case Control Study. Nepal journal of epidemiology. 2010;1(1):22-3.

Von Baum H, Ewi S, Marre R, Suttorp N, Gonschior S, Welte T. Community-acquired Legionella pneumonia: new insights from the German competence network for community acquired pneumonia. Clin Infect Dis. 2008;46(9):1356-64.




How to Cite

Mohammadi, S., Karim, N. A., Talib, R. A., & Amani, R. (2017). Evaluation of quality of life among type 2 diabetes patients. International Journal Of Community Medicine And Public Health, 3(1), 51–56. https://doi.org/10.18203/2394-6040.ijcmph20151485



Original Research Articles